153 studies found for:    "behavior disorders" [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: HLD200 methylphenidate hydrochloride (MPH) Capsules;   Drug: Placebo
22 Not yet recruiting The Efficacy of a Brief Attention Training Technique on Improving Behaviour and Attention in Children With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Attention Training Technique
23 Recruiting Intervention for Teens With ADHD and Substance Use
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Brief Early Intervention;   Behavioral: Parent Training with Adolescent Cognitive Behavioral Therapy;   Drug: Methylphenidate
24 Recruiting A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: HLD200 methylphenidate hydrochloride (MPH) Capsules
25 Recruiting EAA/Therapy for Treating Children With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: EAA/T;   Drug: Methylphenidate;   Drug: Atomoxetine
26 Not yet recruiting Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: mixed amphetamine salts-extended release (MAS-XR);   Drug: Placebo
27 Not yet recruiting Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD
Condition: Attention-Deficit/Hyperactivity Disorder
Intervention: Drug: Methylphenidate HCl ER Capsules
28 Recruiting Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: SHP465;   Drug: Placebo
29 Not yet recruiting Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
Condition: Attention-deficit/Hyperactivity Disorder
Intervention: Drug: SPD489
30 Recruiting Dasotraline Pediatric Extension Study
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Dasotraline
31 Recruiting Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Placebo First, then ORADUR®;   Drug: ORADUR® First, then Placebo
32 Recruiting Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children
Condition: Attention Deficit/Hyperactivity Disorder
33 Recruiting Dasotraline Pediatric ADHD Study
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Dasotraline;   Drug: Placebo Comparator
34 Recruiting Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder
Condition: Attention- Deficit/Hyperactivity Disorder
Intervention: Drug: SPD489
35 Recruiting Neuroendocrine Substrates, Candidate Genes and Endophenotypes in ADHD
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
36 Not yet recruiting The Correlation Between Blood omega3 and ADHD
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Procedure: blood test;   Dietary Supplement: omega3 capsules
37 Not yet recruiting New Technologies to Help Manage ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: enhanced myADHDportal.com;   Other: treatment as usual standard portal
38 Recruiting Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Neurofeedback training;   Behavioral: Computerized cognitive training
39 Recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
40 Recruiting NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: NIRS Neurofeedback

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years